{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:01:40Z","timestamp":1790600500389,"version":"4.1.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,28]]},"DOI":"10.7759\/cureus.117078","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:46:56Z","timestamp":1790599616000},"source":"Crossref","is-referenced-by-count":0,"title":["Microwave Ablation Versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Lucas","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Vasquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay H","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J, et al.. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022, 77:1598-606. 10.1016\/j.jhep.2022.08.021","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: management of hepatocellular carcinoma","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol. 2018, 69:182-236. 10.1016\/j.jhep.2018.03.019","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.10.020","article-title":"BCLC strategy for prognosis prediction and treatment recommendations: the 2026 update","volume":"84","author":"Reig M","year":"2026","unstructured":"Reig M, Sanduzzi-Zamparelli M, Forner A, et al.. BCLC strategy for prognosis prediction and treatment recommendations: the 2026 update. J Hepatol. 2026, 84:631-54. 10.1016\/j.jhep.2025.10.020","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000521665","article-title":"Surgery versus radiofrequency ablation for small hepatocellular carcinoma: a randomized controlled trial (SURF trial)","volume":"11","author":"Takayama T","year":"2022","unstructured":"Takayama T, Hasegawa K, Izumi N, et al.. Surgery versus radiofrequency ablation for small hepatocellular carcinoma: a randomized controlled trial (SURF trial). Liver Cancer. 2022, 11:209-18. 10.1159\/000521665","journal-title":"Liver Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2017162756","article-title":"Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: systematic review of randomized controlled trials with meta-analysis and trial sequential analysis","volume":"287","author":"Xu XL","year":"2018","unstructured":"Xu XL, Liu XD, Liang M, Luo BM. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: systematic review of randomized controlled trials with meta-analysis and trial sequential analysis. Radiology. 2018, 287:461-72. 10.1148\/radiol.2017162756","journal-title":"Radiology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/1754-9485.13613","article-title":"Thermal ablation of hepatocellular carcinoma","volume":"67","author":"Crocetti L","year":"2023","unstructured":"Crocetti L, Scalise P, Bozzi E, Candita G, Cioni R. Thermal ablation of hepatocellular carcinoma. J Med Imaging Radiat Oncol. 2023, 67:817-31. 10.1111\/1754-9485.13613","journal-title":"J Med Imaging Radiat Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i47.5331","article-title":"Percutaneous ablation for perivascular hepatocellular carcinoma: refining the current status based on emerging evidence and future perspectives","volume":"24","author":"Kang TW","year":"2018","unstructured":"Kang TW, Lim HK, Cha DI. Percutaneous ablation for perivascular hepatocellular carcinoma: refining the current status based on emerging evidence and future perspectives. World J Gastroenterol. 2018, 24:5331-7. 10.3748\/wjg.v24.i47.5331","journal-title":"World J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-117410","article-title":"Microwave ablation (MWA): basics, technique and results in primary and metastatic liver neoplasms","volume":"189","author":"Vogl TJ","year":"2017","unstructured":"Vogl TJ, Nour-Eldin NA, Hammerstingl RM, Panahi B, Naguib NN. Microwave ablation (MWA): basics, technique and results in primary and metastatic liver neoplasms. Rofo. 2017, 189:1055-66. 10.1055\/s-0043-117410","journal-title":"Rofo"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/RLI.0000000000001100","article-title":"Local ablation therapy for hepatocellular carcinoma: clinical significance of tumor size, location, and biology","volume":"60","author":"Lee MW","year":"2025","unstructured":"Lee MW, Han S, Gu K, Rhim H. Local ablation therapy for hepatocellular carcinoma: clinical significance of tumor size, location, and biology. Invest Radiol. 2025, 60:53-9. 10.1097\/RLI.0000000000001100","journal-title":"Invest Radiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2024.0550","article-title":"Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendations of the Korean Liver Cancer Association","volume":"25","author":"Han S","year":"2024","unstructured":"Han S, Sung PS, Park SY, et al.. Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendations of the Korean Liver Cancer Association. Korean J Radiol. 2024, 25:773-87. 10.3348\/kjr.2024.0550","journal-title":"Korean J Radiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123796","article-title":"Microwave ablation versus radiofrequency ablation for treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials","volume":"12","author":"Facciorusso A","year":"2020","unstructured":"Facciorusso A, Abd El Aziz MA, Tartaglia N, et al.. Microwave ablation versus radiofrequency ablation for treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Cancers (Basel). 2020, 12:3796. 10.3390\/cancers12123796","journal-title":"Cancers (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-021-03080-1","article-title":"Percutaneous microwave ablation versus radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials","volume":"46","author":"Yu Q","year":"2021","unstructured":"Yu Q, Liu C, Navuluri R, Ahmed O. Percutaneous microwave ablation versus radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Abdom Radiol (NY). 2021, 46:4467-75. 10.1007\/s00261-021-03080-1","journal-title":"Abdom Radiol (NY)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2018181494","article-title":"Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients","volume":"289","author":"Chernyak V","year":"2018","unstructured":"Chernyak V, Fowler KJ, Kamaya A, et al.. Liver Imaging Reporting and Data System (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology. 2018, 289:816-30. 10.1148\/radiol.2018181494","journal-title":"Radiology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma","volume":"82","author":"European Association for the Study of the Liver","year":"2025","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma. J Hepatol. 2025, 82:315-74. 10.1016\/j.jhep.2024.08.028","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13028","article-title":"Percutaneous thermal ablation for primary hepatocellular carcinoma: a systematic review and meta-analysis","volume":"31","author":"Chinnaratha MA","year":"2016","unstructured":"Chinnaratha MA, Chuang MY, Fraser RJ, Woodman RJ, Wigg AJ. Percutaneous thermal ablation for primary hepatocellular carcinoma: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2016, 31:294-301. 10.1111\/jgh.13028","journal-title":"J Gastroenterol Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029321","article-title":"Efficacy and safety of microwave ablation and radiofrequency ablation in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"101","author":"Dou Z","year":"2022","unstructured":"Dou Z, Lu F, Ren L, Song X, Li B, Li X. Efficacy and safety of microwave ablation and radiofrequency ablation in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Medicine (Baltimore). 2022, 101:e29321. 10.1097\/MD.0000000000029321","journal-title":"Medicine (Baltimore)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3109\/02656736.2015.1127434","article-title":"Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"32","author":"Facciorusso A","year":"2016","unstructured":"Facciorusso A, Di Maso M, Muscatiello N. Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia. 2016, 32:339-44. 10.3109\/02656736.2015.1127434","journal-title":"Int J Hyperthermia"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2016.01.020","article-title":"Radiofrequency and microwave ablation of subcapsular hepatocellular carcinoma accessed by direct puncture: safety and efficacy","volume":"85","author":"Francica G","year":"2016","unstructured":"Francica G, Meloni MF, de Sio I, et al.. Radiofrequency and microwave ablation of subcapsular hepatocellular carcinoma accessed by direct puncture: safety and efficacy. Eur J Radiol. 2016, 85:739-43. 10.1016\/j.ejrad.2016.01.020","journal-title":"Eur J Radiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022703","article-title":"Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma: a PRISMA-compliant systematic review and meta-analysis","volume":"99","author":"Han J","year":"2020","unstructured":"Han J, Fan YC, Wang K. Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2020, 99:e22703. 10.1097\/MD.0000000000022703","journal-title":"Medicine (Baltimore)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2015.04.004","article-title":"Microwave ablation compared to radiofrequency ablation for hepatic lesions: a meta-analysis","volume":"26","author":"Huo YR","year":"2015","unstructured":"Huo YR, Eslick GD. Microwave ablation compared to radiofrequency ablation for hepatic lesions: a meta-analysis. J Vasc Interv Radiol. 2015, 26:1139-1146.e2. 10.1016\/j.jvir.2015.04.004","journal-title":"J Vasc Interv Radiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12572","article-title":"Comparison of microwave ablation and surgical resection for treatment of hepatocellular carcinomas conforming to Milan criteria","volume":"29","author":"Shi J","year":"2014","unstructured":"Shi J, Sun Q, Wang Y, et al.. Comparison of microwave ablation and surgical resection for treatment of hepatocellular carcinomas conforming to Milan criteria. J Gastroenterol Hepatol. 2014, 29:1500-7. 10.1111\/jgh.12572","journal-title":"J Gastroenterol Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2021.1869939","article-title":"Microwave ablation determines similar survival outcomes as compared to radiofrequency ablation for the treatment of hepatocellular carcinoma","volume":"15","author":"Khan A","year":"2021","unstructured":"Khan A, Mostowy M, Owusu M, Mutambanengwe M, Habimana S, Bence S, Facciorusso A. Microwave ablation determines similar survival outcomes as compared to radiofrequency ablation for the treatment of hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2021, 15:829-33. 10.1080\/17474124.2021.1869939","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-020-01064-7","article-title":"Combination therapy by transarterial injection of miriplatin-iodized oil suspension with radiofrequency ablation (RFA) versus microwave ablation (MWA) for small hepatocellular carcinoma: a comparison of therapeutic efficacy","volume":"39","author":"Miyamoto N","year":"2021","unstructured":"Miyamoto N, Kanaya M, Fujii T, Kato H, Kudo K, Kinota N. Combination therapy by transarterial injection of miriplatin-iodized oil suspension with radiofrequency ablation (RFA) versus microwave ablation (MWA) for small hepatocellular carcinoma: a comparison of therapeutic efficacy. Jpn J Radiol. 2021, 39:376-86. 10.1007\/s11604-020-01064-7","journal-title":"Jpn J Radiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2478\/rjim-2024-0022","article-title":"Comparative efficacy of microwave ablation versus radiofrequency ablation in hepatocellular carcinoma: a systematic review and meta-analysis of randomized controlled trials","volume":"62","author":"Rey I","year":"2024","unstructured":"Rey I, Darmadi D. Comparative efficacy of microwave ablation versus radiofrequency ablation in hepatocellular carcinoma: a systematic review and meta-analysis of randomized controlled trials. Rom J Intern Med. 2024, 62:374-86. 10.2478\/rjim-2024-0022","journal-title":"Rom J Intern Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.12181","article-title":"The (eternal) debate on microwave ablation versus radiofrequency ablation in BCLC-a hepatocellular carcinoma","volume":"34","author":"Ricci AD","year":"2020","unstructured":"Ricci AD, Rizzo A, Bonucci C, et al.. The (eternal) debate on microwave ablation versus radiofrequency ablation in BCLC-a hepatocellular carcinoma. In Vivo. 2020, 34:3421-9. 10.21873\/invivo.12181","journal-title":"In Vivo"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.67938","article-title":"Comparison of radiofrequency ablation and microwave ablation for management of hepatocellular carcinoma: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Shaqran TM","year":"2024","unstructured":"Shaqran TM, Alharbi J, Al-Hunbusi SK, et al.. Comparison of radiofrequency ablation and microwave ablation for management of hepatocellular carcinoma: a systematic review and meta-analysis of randomized controlled trials. Cureus. 2024, 16:e67938. 10.7759\/cureus.67938","journal-title":"Cureus"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2478\/raon-2021-0030","article-title":"Microwave ablation compared with radiofrequency ablation for the treatment of liver cancer: a systematic review and meta-analysis","volume":"55","author":"Spiliotis AE","year":"2021","unstructured":"Spiliotis AE, G\u00e4belein G, Holl\u00e4nder S, Scherber PR, Glanemann M, Patel B. Microwave ablation compared with radiofrequency ablation for the treatment of liver cancer: a systematic review and meta-analysis. Radiol Oncol. 2021, 55:247-58. 10.2478\/raon-2021-0030","journal-title":"Radiol Oncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2018.1562571","article-title":"Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"36","author":"Tan W","year":"2019","unstructured":"Tan W, Deng Q, Lin S, Wang Y, Xu G. Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia. 2019, 36:264-72. 10.1080\/02656736.2018.1562571","journal-title":"Int J Hyperthermia"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3109\/02656736.2016.1164906","article-title":"'Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis': two issues should be noted","volume":"32","author":"Huang Q","year":"2016","unstructured":"Huang Q, Yang H, Lin QN, Qin X. 'Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis': two issues should be noted. Int J Hyperthermia. 2016, 32:345. 10.3109\/02656736.2016.1164906","journal-title":"Int J Hyperthermia"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.4103\/jmas.jmas_344_22","article-title":"Microwave ablation is superior to radiofrequency ablation in the treatment of hepatocellular carcinoma below 5 cm - a systematic review and meta-analysis","volume":"19","author":"Zhang L","year":"2023","unstructured":"Zhang L, Du F, Zhang Y, Yangdan C, Wang H, Ren L. Microwave ablation is superior to radiofrequency ablation in the treatment of hepatocellular carcinoma below 5 cm - a systematic review and meta-analysis. J Minim Access Surg. 2023, 19:453-8. 10.4103\/jmas.jmas_344_22","journal-title":"J Minim Access Surg"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115949","article-title":"Incomplete radiofrequency ablation enhances invasiveness and metastasis of residual cancer of hepatocellular carcinoma cell HCCLM3 via activating \u03b2-catenin signaling","volume":"9","author":"Zhang N","year":"2014","unstructured":"Zhang N, Wang L, Chai ZT, et al.. Incomplete radiofrequency ablation enhances invasiveness and metastasis of residual cancer of hepatocellular carcinoma cell HCCLM3 via activating \u03b2-catenin signaling. PLoS One. 2014, 9:e115949. 10.1371\/journal.pone.0115949","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1177\/08465371241286795","article-title":"Outcomes and complications of image-guided percutaneous tumour ablation for hepatocellular carcinoma at the Irish National Liver Transplant Centre","volume":"76","author":"Tee SR","year":"2025","unstructured":"Tee SR, Hughes H, Ryan ER, et al.. Outcomes and complications of image-guided percutaneous tumour ablation for hepatocellular carcinoma at the Irish National Liver Transplant Centre. Can Assoc Radiol J. 2025, 76:333-43. 10.1177\/08465371241286795","journal-title":"Can Assoc Radiol J"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2021.0136","article-title":"New next-generation microwave thermosphere ablation for small hepatocellular carcinoma","volume":"27","author":"Tamai H","year":"2021","unstructured":"Tamai H, Okamura J. New next-generation microwave thermosphere ablation for small hepatocellular carcinoma. Clin Mol Hepatol. 2021, 27:564-74. 10.3350\/cmh.2021.0136","journal-title":"Clin Mol Hepatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne JA","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al.. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016, 355:i4919. 10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout J","year":"2014","unstructured":"IntHout J, Ioannidis JP, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol. 2014, 14:25. 10.1186\/1471-2288-14-25","journal-title":"BMC Med Res Methodol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger M","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997, 315:629-34. 10.1136\/bmj.315.7109.629","journal-title":"BMJ"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi S","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019, 22:153-60. 10.1136\/ebmental-2019-300117","journal-title":"Evid Based Ment Health"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer W","year":"2010","unstructured":"Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010, 36:1-48. 10.18637\/jss.v036.i03","journal-title":"J Stat Softw"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt GH","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Sch\u00fcnemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008, 336:924-6. 10.1136\/bmj.39489.470347.AD","journal-title":"BMJ"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-014-3617-4","article-title":"Efficacy and survival analysis of percutaneous radiofrequency versus microwave ablation for hepatocellular carcinoma: an Egyptian multidisciplinary clinic experience","volume":"28","author":"Abdelaziz A","year":"2014","unstructured":"Abdelaziz A, Elbaz T, Shousha HI, Mahmoud S, Ibrahim M, Abdelmaksoud A, Nabeel M. Efficacy and survival analysis of percutaneous radiofrequency versus microwave ablation for hepatocellular carcinoma: an Egyptian multidisciplinary clinic experience. Surg Endosc. 2014, 28:3429-34. 10.1007\/s00464-014-3617-4","journal-title":"Surg Endosc"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(18)30029-3","article-title":"Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial","volume":"3","author":"Vietti Violi N","year":"2018","unstructured":"Vietti Violi N, Duran R, Guiu B, et al.. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial. Lancet Gastroenterol Hepatol. 2018, 3:317-25. 10.1016\/S2468-1253(18)30029-3","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2020.01.008","article-title":"Prospective double-blinded randomized controlled trial of microwave versus radiofrequency ablation for hepatocellular carcinoma (McRFA trial)","volume":"22","author":"Chong CC","year":"2020","unstructured":"Chong CC, Lee KF, Cheung SY, et al.. Prospective double-blinded randomized controlled trial of microwave versus radiofrequency ablation for hepatocellular carcinoma (McRFA trial). HPB (Oxford). 2020, 22:1121-7. 10.1016\/j.hpb.2020.01.008","journal-title":"HPB (Oxford)"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1055\/a-2203-2733","article-title":"Comparison of microwave and radiofrequency ablation for the treatment of small- and medium-sized hepatocellular carcinomas in a prospective randomized trial","volume":"196","author":"Vogl TJ","year":"2024","unstructured":"Vogl TJ, Martin SS, Gruber-Rouh T, Booz C, Koch V, Nour-Eldin NA, Hussainy Said MN. Comparison of microwave and radiofrequency ablation for the treatment of small- and medium-sized hepatocellular carcinomas in a prospective randomized trial. Rofo. 2024, 196:482-90. 10.1055\/a-2203-2733","journal-title":"Rofo"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101269","article-title":"Microwave ablation vs. single-needle radiofrequency ablation for the treatment of HCC up to 4\u00a0cm: a randomized-controlled trial","volume":"7","author":"Sugimoto K","year":"2025","unstructured":"Sugimoto K, Imajo K, Kuroda H, et al.. Microwave ablation vs. single-needle radiofrequency ablation for the treatment of HCC up to 4\u00a0cm: a randomized-controlled trial. JHEP Rep. 2025, 7:101269. 10.1016\/j.jhepr.2024.101269","journal-title":"JHEP Rep"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-07571-5","article-title":"Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis","volume":"31","author":"An C","year":"2021","unstructured":"An C, Li WZ, Huang ZM, et al.. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis. Eur Radiol. 2021, 31:4764-73. 10.1007\/s00330-020-07571-5","journal-title":"Eur Radiol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2020.08.006","article-title":"Microwave ablation versus radiofrequency ablation for perivascular hepatocellular carcinoma: a propensity score analysis","volume":"23","author":"Feng Y","year":"2021","unstructured":"Feng Y, Wang L, Lv H, et al.. Microwave ablation versus radiofrequency ablation for perivascular hepatocellular carcinoma: a propensity score analysis. HPB (Oxford). 2021, 23:512-9. 10.1016\/j.hpb.2020.08.006","journal-title":"HPB (Oxford)"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1111\/hpb.12264","article-title":"Laparoscopic microwave ablation in patients with hepatocellular carcinoma: a prospective cohort study","volume":"16","author":"Cillo U","year":"2014","unstructured":"Cillo U, Noaro G, Vitale A, et al.. Laparoscopic microwave ablation in patients with hepatocellular carcinoma: a prospective cohort study. HPB (Oxford). 2014, 16:979-86. 10.1111\/hpb.12264","journal-title":"HPB (Oxford)"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2016.01.136","article-title":"Microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: a comparison of efficacy at a single center","volume":"27","author":"Potretzke TA","year":"2016","unstructured":"Potretzke TA, Ziemlewicz TJ, Hinshaw JL, et al.. Microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: a comparison of efficacy at a single center. J Vasc Interv Radiol. 2016, 27:631-8. 10.1016\/j.jvir.2016.01.136","journal-title":"J Vasc Interv Radiol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-005-1671-3","article-title":"Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study","volume":"40","author":"Lu MD","year":"2005","unstructured":"Lu MD, Xu HX, Xie XY, et al.. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol. 2005, 40:1054-60. 10.1007\/s00535-005-1671-3","journal-title":"J Gastroenterol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2013.04.025","article-title":"Comparison of two different thermal techniques for the treatment of hepatocellular carcinoma","volume":"82","author":"Ding J","year":"2013","unstructured":"Ding J, Jing X, Liu J, Wang Y, Wang F, Wang Y, Du Z. Comparison of two different thermal techniques for the treatment of hepatocellular carcinoma. Eur J Radiol. 2013, 82:1379-84. 10.1016\/j.ejrad.2013.04.025","journal-title":"Eur J Radiol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076119","article-title":"Therapeutic efficacy of percutaneous radiofrequency ablation versus microwave ablation for hepatocellular carcinoma","volume":"8","author":"Zhang L","year":"2013","unstructured":"Zhang L, Wang N, Shen Q, Cheng W, Qian GJ. Therapeutic efficacy of percutaneous radiofrequency ablation versus microwave ablation for hepatocellular carcinoma. PLoS One. 2013, 8:e76119. 10.1371\/journal.pone.0076119","journal-title":"PLoS One"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000270","article-title":"High local recurrence of early-stage hepatocellular carcinoma after percutaneous thermal ablation in routine clinical practice","volume":"27","author":"Chinnaratha MA","year":"2015","unstructured":"Chinnaratha MA, Sathananthan D, Pateria P, et al.. High local recurrence of early-stage hepatocellular carcinoma after percutaneous thermal ablation in routine clinical practice. Eur J Gastroenterol Hepatol. 2015, 27:349-54. 10.1097\/MEG.0000000000000270","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-015-0355-6","article-title":"Ablation therapy of hepatocellular carcinoma: a comparative study between radiofrequency and microwave ablation","volume":"40","author":"Vogl TJ","year":"2015","unstructured":"Vogl TJ, Farshid P, Naguib NN, et al.. Ablation therapy of hepatocellular carcinoma: a comparative study between radiofrequency and microwave ablation. Abdom Imaging. 2015, 40:1829-37. 10.1007\/s00261-015-0355-6","journal-title":"Abdom Imaging"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2016.01.001","article-title":"Long-term outcomes of microwave versus radiofrequency ablation for hepatocellular carcinoma by surgical approach: a retrospective comparative study","volume":"40","author":"Lee KF","year":"2017","unstructured":"Lee KF, Wong J, Hui JW, et al.. Long-term outcomes of microwave versus radiofrequency ablation for hepatocellular carcinoma by surgical approach: a retrospective comparative study. Asian J Surg. 2017, 40:301-8. 10.1016\/j.asjsur.2016.01.001","journal-title":"Asian J Surg"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5527-2","article-title":"Comparison of laparoscopic microwave to radiofrequency ablation of small hepatocellular carcinoma (\u22643 cm)","volume":"24","author":"Santambrogio R","year":"2017","unstructured":"Santambrogio R, Chiang J, Barabino M, Meloni FM, Bertolini E, Melchiorre F, Opocher E. Comparison of laparoscopic microwave to radiofrequency ablation of small hepatocellular carcinoma (\u22643 cm). Ann Surg Oncol. 2017, 24:257-63. 10.1245\/s10434-016-5527-2","journal-title":"Ann Surg Oncol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-017-0183-x","article-title":"Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma","volume":"36","author":"Xu Y","year":"2017","unstructured":"Xu Y, Shen Q, Wang N, Wu PP, Huang B, Kuang M, Qian GJ. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma. Chin J Cancer. 2017, 36:14. 10.1186\/s40880-017-0183-x","journal-title":"Chin J Cancer"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312629","article-title":"Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial","volume":"66","author":"Yu J","year":"2017","unstructured":"Yu J, Yu XL, Han ZY, et al.. Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial. Gut. 2017, 66:1172-3. 10.1136\/gutjnl-2016-312629","journal-title":"Gut"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14929","article-title":"Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis","volume":"48","author":"Liu W","year":"2018","unstructured":"Liu W, Zheng Y, He W, et al.. Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis. Aliment Pharmacol Ther. 2018, 48:671-81. 10.1111\/apt.14929","journal-title":"Aliment Pharmacol Ther"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2019.01.34","article-title":"Percutaneous radiofrequency versus microwave ablation for management of hepatocellular carcinoma: a randomized controlled trial","volume":"10","author":"Kamal A","year":"2019","unstructured":"Kamal A, Elmoety AA, Rostom YA, Shater MS, Lashen SA. Percutaneous radiofrequency versus microwave ablation for management of hepatocellular carcinoma: a randomized controlled trial. J Gastrointest Oncol. 2019, 10:562-71. 10.21037\/jgo.2019.01.34","journal-title":"J Gastrointest Oncol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-020-02549-8","article-title":"Factors associated with tumor progression after percutaneous ablation of hepatocellular carcinoma: comparison between monopolar radiofrequency and microwaves. Results of a propensity score matching analysis","volume":"43","author":"Bouda D","year":"2020","unstructured":"Bouda D, Barrau V, Raynaud L, et al.. Factors associated with tumor progression after percutaneous ablation of hepatocellular carcinoma: comparison between monopolar radiofrequency and microwaves. Results of a propensity score matching analysis. Cardiovasc Intervent Radiol. 2020, 43:1608-18. 10.1007\/s00270-020-02549-8","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227242","article-title":"Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: a multiple centers retrospective cohort study with propensity score matching","volume":"15","author":"Du S","year":"2020","unstructured":"Du S, Yang JZ, Chen J, Zhou WG, Sun YY. Comparisons of recurrence-free survival and overall survival between microwave versus radiofrequency ablation treatment for hepatocellular carcinoma: a multiple centers retrospective cohort study with propensity score matching. PLoS One. 2020, 15:e0227242. 10.1371\/journal.pone.0227242","journal-title":"PLoS One"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2020.06.014","article-title":"Comparison of radiofrequency and microwave ablation and identification of risk factors for primary treatment failure and local progression","volume":"67","author":"McDevitt JL","year":"2020","unstructured":"McDevitt JL, Collard MD, Murphy RP, Sutphin PD, Yopp AC, Singal AG, Kalva SP. Comparison of radiofrequency and microwave ablation and identification of risk factors for primary treatment failure and local progression. Clin Imaging. 2020, 67:146-51. 10.1016\/j.clinimag.2020.06.014","journal-title":"Clin Imaging"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2020.1983","article-title":"Short term treatment results of local ablation with water-cooled microwave antenna for liver cancer: comparison with radiofrequency ablation","volume":"12","author":"Suwa K","year":"2020","unstructured":"Suwa K, Seki T, Tsuda R, et al.. Short term treatment results of local ablation with water-cooled microwave antenna for liver cancer: comparison with radiofrequency ablation. Mol Clin Oncol. 2020, 12:230-6. 10.3892\/mco.2020.1983","journal-title":"Mol Clin Oncol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-021-03105-9","article-title":"Radiofrequency versus microwave ablation for hepatocellular carcinoma within the Milan criteria in challenging locations: a retrospective controlled study","volume":"46","author":"Han X","year":"2021","unstructured":"Han X, Ni JY, Li SL, et al.. Radiofrequency versus microwave ablation for hepatocellular carcinoma within the Milan criteria in challenging locations: a retrospective controlled study. Abdom Radiol (NY). 2021, 46:3758-71. 10.1007\/s00261-021-03105-9","journal-title":"Abdom Radiol (NY)"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061295","article-title":"Comparing the safety and efficacy of microwave ablation using Thermosphere technology versus radiofrequency ablation for hepatocellular carcinoma: a propensity score-matched analysis","volume":"13","author":"Kuroda H","year":"2021","unstructured":"Kuroda H, Nagasawa T, Fujiwara Y, et al.. Comparing the safety and efficacy of microwave ablation using Thermosphere technology versus radiofrequency ablation for hepatocellular carcinoma: a propensity score-matched analysis. Cancers (Basel). 2021, 13:1295. 10.3390\/cancers13061295","journal-title":"Cancers (Basel)"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-021-03008-9","article-title":"Efficacy of microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score analysis","volume":"46","author":"Suwa K","year":"2021","unstructured":"Suwa K, Seki T, Aoi K, et al.. Efficacy of microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score analysis. Abdom Radiol (NY). 2021, 46:3790-7. 10.1007\/s00261-021-03008-9","journal-title":"Abdom Radiol (NY)"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11020302","article-title":"A real-world comparative study of microwave and radiofrequency ablation in treatment-na\u00efve and recurrent hepatocellular carcinoma","volume":"11","author":"Lee SK","year":"2022","unstructured":"Lee SK, Chung DJ, Cho SH. A real-world comparative study of microwave and radiofrequency ablation in treatment-na\u00efve and recurrent hepatocellular carcinoma. J Clin Med. 2022, 11:302. 10.3390\/jcm11020302","journal-title":"J Clin Med"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.jcrt_1466_21","article-title":"Comparison of percutaneous microwave ablation with radiofrequency ablation for hepatocellular carcinoma adjacent to major vessels: a retrospective study","volume":"18","author":"Shen Q","year":"2022","unstructured":"Shen Q, Wang N, Wu PP, Tan BB, Qian GJ. Comparison of percutaneous microwave ablation with radiofrequency ablation for hepatocellular carcinoma adjacent to major vessels: a retrospective study. J Cancer Res Ther. 2022, 18:329-35. 10.4103\/jcrt.jcrt_1466_21","journal-title":"J Cancer Res Ther"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-022-08537-5","article-title":"Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study","volume":"32","author":"Zheng H","year":"2022","unstructured":"Zheng H, Liu K, Yang Y, et al.. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study. Eur Radiol. 2022, 32:4657-66. 10.1007\/s00330-022-08537-5","journal-title":"Eur Radiol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2023.110860","article-title":"Microwave ablation versus radiofrequency ablation as bridge therapy in potentially transplantable patients with single HCC\u00a0\u2264\u00a03\u00a0cm: a propensity score-matched study","volume":"164","author":"Wang X","year":"2023","unstructured":"Wang X, Yu H, Zhao F, et al.. Microwave ablation versus radiofrequency ablation as bridge therapy in potentially transplantable patients with single HCC\u00a0\u2264\u00a03\u00a0cm: a propensity score-matched study. Eur J Radiol. 2023, 164:110860. 10.1016\/j.ejrad.2023.110860","journal-title":"Eur J Radiol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-23-1939","article-title":"Radiofrequency ablation versus microwave ablation for hepatocellular carcinoma with cirrhosis: a propensity score analysis","volume":"13","author":"Xiong Y","year":"2024","unstructured":"Xiong Y, Zhang Y, Hu C. Radiofrequency ablation versus microwave ablation for hepatocellular carcinoma with cirrhosis: a propensity score analysis. Transl Cancer Res. 2024, 13:1807-20. 10.21037\/tcr-23-1939","journal-title":"Transl Cancer Res"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.14221","article-title":"Microwave thermosphere ablation versus radiofrequency ablation in hepatocellular carcinoma: optimizing treatment strategies for tumor size and malignancy grade","volume":"55","author":"Tamai H","year":"2025","unstructured":"Tamai H, Okamura J. Microwave thermosphere ablation versus radiofrequency ablation in hepatocellular carcinoma: optimizing treatment strategies for tumor size and malignancy grade. Hepatol Res. 2025, 55:1274-84. 10.1111\/hepr.14221","journal-title":"Hepatol Res"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2025.2524389","article-title":"Microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score matching and inverse probability weighting analysis","volume":"42","author":"Yang W","year":"2025","unstructured":"Yang W, Li X, Tan X. Microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score matching and inverse probability weighting analysis. Int J Hyperthermia. 2025, 42:2524389. 10.1080\/02656736.2025.2524389","journal-title":"Int J Hyperthermia"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2024.12.010","article-title":"Microwave ablation versus radiofrequency ablation for hepatocellular carcinoma in patients with decompensated cirrhosis","volume":"27","author":"Yu H","year":"2025","unstructured":"Yu H, Yang Y, Lin X, et al.. Microwave ablation versus radiofrequency ablation for hepatocellular carcinoma in patients with decompensated cirrhosis. HPB (Oxford). 2025, 27:377-84. 10.1016\/j.hpb.2024.12.010","journal-title":"HPB (Oxford)"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2025.01.003","article-title":"Comparison of radiofrequency ablation, microwave ablation and high-intensity focused ultrasound for hepatocellular carcinoma: a retrospective study","volume":"27","author":"Cheung WS","year":"2025","unstructured":"Cheung WS, She WH, Tsang SH, Dai WC, Chan AC, Cheung TT. Comparison of radiofrequency ablation, microwave ablation and high-intensity focused ultrasound for hepatocellular carcinoma: a retrospective study. HPB (Oxford). 2025, 27:607-13. 10.1016\/j.hpb.2025.01.003","journal-title":"HPB (Oxford)"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v32.i2.113810","article-title":"Multibipolar radiofrequency vs single needle microwave ablation for the treatment of newly diagnosed hepatocellular carcinoma","volume":"32","author":"Bahloul C","year":"2026","unstructured":"Bahloul C, Rode A, Pradat P, et al.. Multibipolar radiofrequency vs single needle microwave ablation for the treatment of newly diagnosed hepatocellular carcinoma. World J Gastroenterol. 2026, 32:113810. 10.3748\/wjg.v32.i2.113810","journal-title":"World J Gastroenterol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2025.1108","article-title":"Comparative outcomes of no-touch radiofrequency ablation versus tumor-puncture microwave ablation for small hepatocellular carcinoma","volume":"27","author":"Kim JH","year":"2026","unstructured":"Kim JH, Park SJ, Chung DJ, Hong HP, Lee JK, Yoon CJ, Lee JM. Comparative outcomes of no-touch radiofrequency ablation versus tumor-puncture microwave ablation for small hepatocellular carcinoma. Korean J Radiol. 2026, 27:34-47. 10.3348\/kjr.2025.1108","journal-title":"Korean J Radiol"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2023.2247564","article-title":"Ablative margins in percutaneous thermal ablation of hepatic tumors: a systematic review","volume":"23","author":"Verdonschot KH","year":"2023","unstructured":"Verdonschot KH, Arts S, Van den Boezem PB, de Wilt JH, F\u00fctterer JJ, Stommel MW, Overduin CG. Ablative margins in percutaneous thermal ablation of hepatic tumors: a systematic review. Expert Rev Anticancer Ther. 2023, 23:977-93. 10.1080\/14737140.2023.2247564","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee QM","year":"2019","unstructured":"Anstee QM, Reeves HL, Kotsiliti E, Govaere O, Heikenwalder M. From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol. 2019, 16:411-28. 10.1038\/s41575-019-0145-7","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.08.012","article-title":"Epidemiology and risk-stratification of NAFLD-associated HCC","volume":"75","author":"Ioannou GN","year":"2021","unstructured":"Ioannou GN. Epidemiology and risk-stratification of NAFLD-associated HCC. J Hepatol. 2021, 75:1476-84. 10.1016\/j.jhep.2021.08.012","journal-title":"J Hepatol"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021203715","article-title":"Consensus guidelines for the definition of time-to-event end points in image-guided tumor ablation: results of the SIO and DATECAN initiative","volume":"301","author":"Puijk RS","year":"2021","unstructured":"Puijk RS, Ahmed M, Adam A, et al.. Consensus guidelines for the definition of time-to-event end points in image-guided tumor ablation: results of the SIO and DATECAN initiative. Radiology. 2021, 301:533-40. 10.1148\/radiol.2021203715","journal-title":"Radiology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/522584-microwave-ablation-versus-radiofrequency-ablation-for-hepatocellular-carcinoma-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:46:57Z","timestamp":1790599617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/522584-microwave-ablation-versus-radiofrequency-ablation-for-hepatocellular-carcinoma-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":84,"URL":"https:\/\/doi.org\/10.7759\/cureus.117078","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,28]]}}}